Piotr Grodzinski

Piotr Grodzinski is the Director of the Office of Cancer Nanotechnology Research (OCNR) at the National Cancer Institute, where he has been responsible for the NCI Alliance for Nanotechnology in Cancer — the world's largest government investment in cancer nanotechnology. His office has funded over $200 million in nanomedicine research, establishing the Cancer Nanotechnology Laboratories (CNL) Network across the USA, the Nanotechnology Characterization Laboratory (NCL), and the Molecular Diagnostics and Therapeutics nanotechnology networks. Grodzinski previously led nanotechnology research at Motorola Labs, developing DNA chips and microfluidic diagnostic platforms. His research bridges nanomaterial science, cancer biology, and clinical translation, with emphasis on developing standardized protocols for characterizing nanomedicine candidates for regulatory approval.

Piotr Grodzinski 是美国国家癌症研究所癌症纳米技术研究办公室主任，负责领导NCI癌症纳米技术联盟——全球最大的政府癌症纳米技术投资项目。 他的办公室已资助了超过2亿美元的纳米医学研究，在美国建立了癌症纳米技术实验室（CNL）网络、纳米技术表征实验室（NCL）以及分子诊断与治疗纳米技术网络。